Title of Invention

PROCESS FOR MANUFACTURING ENTACAPONE

Abstract A new process for manufacturing entacapone comprising reacting 3,4-dihydroxy-5-nilrobenzaldehyde with N,N-di- ethyl-2-cyanoacetamide in the presence of a catalyst in a C 4 to 8 alcohol at reduced pressure and at a temperature of at least 70 °C, cooling the mixture to a temperature of 30 °C or below, seeding the mixture with N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-ni- trophenyl)acrylamide comprising at least 10 % of the Z-isomer by weight in the seeding crystals, cooling the mixture to a temperature of 5 °C or below, isolating the crystallized product and converting the obtained mixture of the E and Z-isomers of N,N-di- ethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide to the E-isomer (entacapone).
Full Text

PROCESS FOR MANUFACTURING ENTACAPONE
[001 ] The present invention relates to a new process for manufacturing entacapone.
BACKGROUND OF THE INVENTION
[002] Entacapone (E-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-
nitrophenyl)acrylamide) is a catechol-O-methyl transferase (COMT) inhibitor often used
in combination with levodopa and a dopa decarboxylase (DDC) inhibitor in the treatment
of Parkinson's disease. Entacapone is commercially available in a stand-alone formulation
under the trademarks Comtess® and Comtan®, and under trademark Stalevo® in a fixed
combination (levodopa:carbidopa:entacapone: 50 mg:12.5 mg:200 mg, 100 mg:25
mg:200 mg and 150 mg:37.5 mg:200 mg).
[003] U.S. Patent No. 5,446,194 discloses a method for the preparation of N,N-
diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide by refluxing a solution
containing 3,4-dihydroxy-5-nitrobenzaldehyde, N,N-diethyl-2-cyanoacetamide and a
catalytic amount of piperidine acetate in dry ethanol. The yield of said method is 73 %.
The product is a crude mixture of the E and Z isomers of N,N-diethyl-2-cyano-3-(3,4-
dihydroxy-5-nitrophenyl)acrylamide having a melting point of 153 °C - 156 °C. The
condensation reaction used in U.S. Patent No. 5,446,194 is called a Knoevenagel
condensation.
[004] U.S. Patent No. 5,135,950 discloses aprocess for the preparation of a stable
and crystallographically essentially pure polymorphic form A of E-N,N-diethyl-2-cyano-
3-(3,4-dihydroxy-5-nitrophenyl)acrylamide having a melting point of 162 °C - 163 °C.
Said process comprises crystallization of the above described crude mixture of the E and
Z isomers of N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide from a
lower aliphatic carboxylic acid containing a catalytic amount of hydrochloric or
hydrobromic acid. The yield of said crystallographically pure polymorphic form A is 70-
80%.

[005] WO 2005/070881 purports to disclose a process for manufacturing the stable
polymorphic form A of E-N,N-diemyl-2-cyano-3-(3,4-dihydroxy-5-
nitrophenyl)acrylamide without isolating a crude solid isomeric mixture of N,N-diethyl-2-
cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide. In said method, the Knoevenagel
condensation step is carried out in an alcohol such as methanol, ethanol, isopropanol,
isobutanol, n-butanol, preferably isopropanol, at reflux temperature in the presence of a
suitable organic base such as piperidine, N-methylmorpholine, pyridine, piperazine etc.,
preferably piperidine base. After the completion of the reaction, the mixture is poured into
a mixture of chilled water and ethyl acetate. The pH of the solution is adjusted to between
3.5 and 4.0 by adding acid. The ethyl acetate layer is separated, washed with water and
concentrated to obtain the (E)-isomer of polymorphic form A. A serious drawback of the
method disclosed in WO 2005/070881 is that the total yield of the process is low, as the
(Z)-isomer (about 30 %) formed during the reaction is not recovered and remains in the
reaction solution, thus interfering with the crystallization of the E-isomer.
[006] WO 2005/063696 purports to disclose a method for producing N,N-diethyl-2-
cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide by heating 3,4-dihydroxy-5-
nitrobenzaldehyde, raw N,N-diethyl-2-cyanoacetamide, acetic acid and diethyl amine in
toluene, and by removing the water formed during the reaction through azeotropic
distillation. A significant drawback of this method is that a large amount of solvent has to
be used.
SUMMARY OF THE INVENTION
[007] Applicants have discovered a process for manufacturing entacapone, which is
industrially applicable due to its good quality and yield, controllability, and use of
desirably low amounts of reagents and/or solvents.
[008] One aspect of the invention is a process for manufacturing E-N,N-diethyl-2-
cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (entacapone), comprising:

a) reacting 3,4-dihydroxy-5-nitrobenzaldehyde with N,N-diethyl-2-cyanoacetamide
in the presence of a catalyst in a C 4 to 8 alcohol at reduced pressure and at a
temperature of at least 70 °C;
b) optionally cooling the resulting mixture from step a);
c) optionally seeding the resulting mixture from step a) or step b) with N,N-diethyl-
2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide comprising at least 60 % of
the E-isomer by weight in the seeding crystals;
d) cooling the resulting mixture from step a) or step b) or step c) to a temperature of
30 °C or below;
e) seeding the cooled mixture from step d) with N,N-diethyl-2-cyano-3-(3,4-
dihydroxy-5-nitrophenyl)acrylamide comprising at least 10 % of the Z-isomer by
weight in the seeding crystals;
f) cooling the mixture from step e) to a temperature of 5 °C or below;
g) isolating the crystallized product from the mixture; and
h) converting the obtained mixture of E- and Z-isomers of N,N-diethyl-2-cyano-3-
(3,4-dihydroxy-5-nitrophenyl)acrylamide to the E-isomer of N,N-diethyl-2-cyano-
3-(3}4-dihydroxy-5-nitrophenyl)acrylamide.
[009] Additional aspects and advantages of the invention will be set forth in part in
the description which follows, and in part will be obvious from the description, or may be
learned by the practice of the invention. The objects and the advantages of the invention
will be realized and attained by means of the elements and combinations particularly
pointed out in the appended claims.
[0010] It is to be understood that both the foregoing general description and the
following detailed description are exemplary and explanatory only and do not restrict the
invention, as claimed.

DETAILED DESCRIPTION OF THE INVENTION
[0011] The applicants have now found that it is possible to manufacture entacapone
with a good yield through a process, which is easy to control, and does not necessitate the
use of large amounts of reagents including catalysts and/or solvents.
[0012] The process of the invention comprises the following steps:
a) reacting 3,4-dihydroxy-5-nitrobenzaldehyde with N,N-diethyl-2-cyanoacetamide in
the presence of a catalyst in a C 4 to 8 alcohol at reduced pressure and at a temperature of
at least 70 °C;
b) optionally cooling the resulting mixture from step a);

c) optionally seeding the resulting mixture from step a) or step b) with N,N-diethyl-
2-cyano-3-(3,4-dihydroxy-5-nitrophenyI)acrylamide comprising at least 60 % of
the E-isomer by weight in the seeding crystals;
d) cooling the resulting mixture from step a) or step b) or step c) to a temperature of
30 °C or below;
e) seeding the cooled mixture from step d) with N,N-diethyl-2-cyano-3-(3,4-
dihydroxy-5-nitrophenyl)acrylamide comprising at least 10 % of the Z-isomer by
weight in the seeding crystals;
i) cooling the mixture from step e) to a temperature of 5 °C or below;
g) isolating the crystallized product from the mixture; and
h) converting the obtained mixture of E- and Z-isomers of N,N-diethyl-2-cyano-3-
(3,4-dihydroxy-5-nitrophenyl)acrylamide to the E-isomer of N,N-diethyl-2-cyano-
3-(3,4-dihydroxy-5-nitrophenyl)acrylamide.

Representative embodiments
[0013] The reaction between 3,4-dihydroxy-5-nitrobenzaldehyde and N,N-diethyl-2-
cyanoacetamide is carried out in a straight or branched chained C4 to C8 alcohol, such as
n-butanol or isoamyl alcohol. Performed under reduced pressure (i.e., less than
atmospheric pressure), the reaction maybe carried out, for example, at a pressure of 80
kPa or below, or at a pressure of from 10 to 80 kPa. The reaction takes place at a
temperature of at least 70 °C. For instance, the reaction temperature may be from 70 to
115 °C, from 75 to 105 °C, or from 80 to 85 °C.
[0014] The reaction between 3,4-dihydroxy-5-nitrobenzaldehyde and N,N-diethyl-2-
cyanoacetamide is carried out in the presence of a catalyst, such as organic amines and/or
salts thereof. Example catalysts include one or more of methylamine hydrochloride,
piperidine, N-methylmorpholine, pyridine and piperazine. For instance, the reaction may
be carried out in the presence of methylamine hydrochloride and piperidine, in the
presence at least one organic amine and at least one organic acid, e.g. in the presence of
piperidine and acetic acid, in the presence of methylamine, piperidine and acetic acid, or
in the presence of piperidine and formic acid.
[0015] In one embodiment of the invention, the reaction between 3,4-dihydroxy-5-
nitrobenzaldehyde and N,N-diethyl-2-cyanoacetamide is facilitated using water
separation. Different techniques may be used to achieve water separation, such as
azeotropic distillation and Dean Stark water separation. Water separation may also be
achieved by adding to the reaction mixture one or more components capable of absorbing
water, such as molecular sieves, carbonates or sulphates of alkali earth metals or alkali
metals. In a similar way, one or more components capable of removing water through a
chemical reaction such as carbodiimides, e.g. cyclohexylcarbodiimides maybe added.
[0016] The reaction may take place over a time period sufficient to react 3,4-
dihydroxy-5-nitrobenzaldehyde with N,N-diethyl-2-cyanoacetamide. Example reaction
times include from 45 minutes to 10 hours, from 45 minutes to 6 hours, or from 2 hours to
5 hours.

[0017] The mixture produced from reaction step a) is optionally cooled in step b), for
example, cooled to a temperature of from 70 to 75 °C. The mixture produced from
reaction step a), or the optionally cooled mixture from step b), may be optionally seeded
in step c) with N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide
comprising at least 60 % of the E-isomer in the seeding crystals. In one embodiment, the
amount of the E-isomer in optional step c) is from 65 to 100 % of the seeding crystals.
[0018] The mixture produced from reaction step a), or the optionally cooled mixture
from step b), or the optionally seeded mixture from step c), is then cooled in step d) to a
temperature of 30 °C or below, for example to a temperature of from 25 to 30 °C. In one
embodiment, the mixture is cooled in step d) to a temperature of from 25 to 30 °C and the
cooling rate is from 10 to 30 °C per hour.
[0019] The cooled mixture from step d) is then seeded in step e) with N,N-diethyl-2-
cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide comprising at least 10 % of the Z-
isomer in the seeding crystals. In one embodiment, the amount of the Z-isomer in step e)
is from 20 to 100 % of the seeding crystals.
[0020] In step f) of the invention, the seeded mixture from step e) is cooled to a
temperature of 5 °C or below, for example to a temperature of from -5 to 5 °C. In one
embodiment, me mixture is cooled in step f) at a cooling rate of from 2 to 20 °C per hour,
or at a cooling rate of from 3 to 10 °C per hour.
[0021 ] The isolation of step g) may be carried out using any isolation procedure used
to isolate solids from liquids, for instance filtering. The isolated solid is then washed.
The purpose of the washing is to replace the impure liquid in the filtering cake and to
separate the catalyst and possible other agents, for instance water removing agents, from
the product. In case organic amines are used as catalysts (as opposed to their salts), the
removal of the catalyst maybe facilitated by acidifying the reaction mixture before the
isolation.
[0022] In step h) of the invention, the mixture of the Z- and E-isomers of N,N-diethyl-
2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide is converted to the E-isomer. In one

embodiment, the mixture is converted to a crystallographically essentially pure polymorph
A of the E-isomer having principal X-Ray powder diffraction (XRD) peaks at 9.0,21.9
and 23.3 when performed by Diffractomer Philips X'Pert PRO (PANalytical). A copper
target X-ray (wavelength 0.1541nm) tube was operated with the power of 45kV x 40 mA.
A real time multiple strip detecteor X'Celerator was used. Polymorph A may be made, for
instance, as disclosed in U.S. Patent No. 5,135,950 which is incorporated herein by
reference.
[0023] In one embodiment, the mixture is converted to the polymorph D of the E-
isomer having principal XRD peaks at 6.8,24.6 and 27.4 when measured using the same
equipment and conditions as above. Polymorph D may be prepared by several methods,
for instance, those disclosed in WO 2005/066117 and WO 2005/063696 incorporated
herein by reference.
[0024] One representative embodiment of the invention comprises the following
steps:
a) reacting 3,4-dihydroxy-5-nitrobenzaldehyde with N,N-diethyl-2-cyanoacetamide in
the presence of at least one organic amine and/or its salt in n-butanol at a temperature of
from 80 to 85 °C;
b) optionally neutralizing the organic amine and/or cooling the resulting mixture to a
temperature of from 70 to 75 °C;
c) optionally seeding the resulting mixture from step b) with N,N-diethyl-2-cyano-3-
(3,4-dihydroxy-5-nitrophenyl)acrylamide comprising from 60 to 100 % of the E-
isomer by weight in the seeding crystals
d) cooling the resulting mixture from step c) to a temperature of from 25 to 30 °C;
e) seeding the cooled mixture from step d) with N,N-diethyl-2-cyano-3-(3,4-
dihydroxy-5-nitrophenyl)acrylamide comprising from 10 % to 100 % of the Z-
isomer by weight in the seeding crystals;

f) cooling the mixture from step e) to a temperature of from -5 to 5 °C;
g) isolating the crystallized product from the mixture; and
h) converting the obtained mixture of E- and Z-isomers of N,N-diethyl-2-cyano-3-
(3,4-dihydroxy-5-nitrophenyl)acrylamide to the E-isomer of N,N-diethyl-2-cyano-
3-(3,4-dihydroxy-5-nitrophenyl)acrylamide.
[0025] Another representative embodiment of the invention comprises the following
steps:
a) reacting 3,4-dihydroxy-5-nitrobenzaldehyde withN,N-diethyl-2-cyanoacetamide in
the presence of at least one organic amine and/or its salt in isoamyl alcohol at a
temperature of from 85 to 95 °C;
b) optionally neutralizing the organic amine and/or cooling the resulting mixture to a
temperature of from 70 to 75 °C;
c) optionally seeding the resulting mixture from step b) with N,N-diethyI-2-cyano-3-
(3,4-dihydroxy-5-nitrophenyl)acrylamide comprising from 60 to 100 % of the E-
isomer by weight in the seeding crystals;
d) cooling the resulting mixture from step c) to a temperature of from 25 to 30 °C;
e) seeding the cooled mixture from step d) with N,N-diethyl-2-cyano-3 -(3,4-
dihydroxy-5-nitrophenyl)acrylamide comprising from 10 % to 100 % of the Z-
isomer by weight in the seeding crystals;
f) cooling the mixture from step e) to a temperature of from -5 to 5 °C;
g) isolating the crystallized product from the mixture; and
h) converting the obtained mixture of E- and Z-isomers of N,N-diethyl-2-cyano-3-
(3,4-dihydroxy-5-nitrophenyl)acrylamide to the E-isomer of N,N-diethyl-2-cyano-
3-(3,4-dihydroxy-5-nitrophenyl)acrylamide.

[0026] In one embodiment of the above-described two representative processes, a
mixture of an organic amine and a salt of another organic amine is used in step a),
wherein said organic amine is piperidine and the salt is memylamine hydrochloride.
[0027] If an organic amine is used in step a) (as opposed to its salt) it is possible to
facilitate its later removal by neutralizing it after the completion of the reaction (e.g. in
step b), for example by adding first water and then an acid (or an aqueous mixture of an
acid), for instance a strong acid such as sulphuric acid or hydrochloric acid.
[0028] As mentioned above, entacapone is a catechol-O-methyl transferase (COMT)
inhibitor that can be used in combination with levodopa and a dopa decarboxylase (DDC)
inhibitor to treat Parkinson's disease. The pharmacologically effective amount of
entacapone is dependent on numerous factors known to those skilled in the art, such as,
•the severity of the condition of the patient, the frequency and the desired duration of use,
etc. The amount of entacapone in an appropriate formulation is typically from 25 to 400
mg, e.g. 25 to 300 mg, especially 50 to 200 mg.
[0029] All levodopa+carbidopa (or benserazide respectively) combinations may be
used together with the entacapone manufactured according to the process of the invention.
They are commercially available as combination tablets sold in Europe under, for
instance, the following trademarks: Nacom® (distributed by X), Sinemet® (distributed by
X). Levodopa and benserazide are commercially available as combination tablet in
Europe under the trademark Madopar® (distributed by Roche).
[0030] The invention will be further clarified by the following non-limiting examples.
EXAMPLES
Example 1 Mixture of the E and Z isomers of N.N-diemvl-2-cyano-3-(3,4-dfoyclroxy-5-
nitrophenvDacrvlamide
[0031] A vessel is charged with 240 ml of n-butanol, 120 g of 3,4-dihydroxy-5-
nitrobenzaldehyde, 4.8 g of memylamine hydrochloride, 122 g of N,N-
diethylcyanoacetamide and 7.2 ml of piperidine. The temperature is raised using water

separation under vacuum to about 82 °C and the reaction mixture is boiled at this
temperature using water separation for 4 hours. The reaction is followed using HPLC.
[0032] After completing the reaction 240 ml of hot water is added to the reaction
mixture and 2.4 ml of strong sulphuric acid is added.
[0033] The reaction mixture is cooled to a temperature of 75 °C and seeded with
crude N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (comprises 70 %
by weight of the E- isomer). After seeding the mixture is cooled to about 28 °C within 3
hours, during which time the E isomer crystallizes.
[0034] The reaction mixture is seeded with a mixture of the E and Z isomers of N,N-
diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (comprises about 30 % by
weight of the Z- isomer) and mixed at about 28 °C for two hours. Thereafter the mixture
is cooled slowly to 0 °C during which time the Z isomer crystallizes.
[0035] The mixture is filtered and washed twice with 60 ml of cold water and the
filtering cake is dried. The yield is about 90 % and the purity over 99.5 %.
Example 2 Mixture of the E and Z isomers of N,N-diethvl-2-cvano-3-(3,4-dihvdroxv-5-
nitrophenyDacrylamide
[0036] A vessel is charged with 180 ml of n-butanol, 120 g of 3,4-dihydroxy-5-
nitrobenzaldehyde, 2.9 g of methylamine hydrochloride, 110 g of N,N-
diethylcyanoacetamide and 4.3 ml of piperidine. The temperature is raised using water
separation under vacuum to about 82 °C and the reaction mixture is boiled at this
temperature using water separation for 5 hours. The reaction is followed using HPLC.
[0037] After completing the reaction 180 ml of hot water is added to the reaction
mixture and 12 ml of strong sulphuric acid is added.
[0038] Thereaction mixture is cooled to a temperature of 75 °C and seeded with
crude N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (comprises 70 %

by weight of the E- isomer). After seeding the mixture is cooled to about 28 °C within 2
hours, during which time the E isomer crystallizes.
[0039] The reaction mixture is seeded with a mixture of the E and Z isomers of N,N-
diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (comprises about 30 % by
weight of the Z- isomer) and mixed at about 28 °C for two hours. Thereafter the mixture
is cooled slowly to 0 °C during which time the Z isomer crystallizes.
[0040] The mixture is filtered and washed twice with 100 ml of cold water and the
filtering cake is dried. The yield is about 96% and the purity over 99.5 %.
Example 3 Mixture of the E and Z isomers of N,N-diethvl-2-cvano-3-(3.4-dihvdroxv-5-
nitrophenvDacrvlamide
[0041] A vessel is charged with 100 ml of isoamylalcohol (3-methyl-butanol), 50 g of
3,4-dihyroxy-5-nitrobenzaldehyde, 2 g of methylamine hydrochloride, 50 g of N,N-
diethylcyanoacetamide and 3 ml of piperidine. The temperature is raised using water
separation under vacuum to about 90 °C and the reaction mixture is boiled at this
temperature using water separation for 3 hours. The reaction is followed using HPLC.
[0042] After completing the reaction 220 ml of hot water is added to the reaction
mixture and 1 ml of strong sulphuric acid is added.
[0043] The reaction mixture is cooled to a temperature of 75 °C and seeded with
crude N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (comprises 70 %
by weight of the E- isomer). After seeding the mixture is cooled to about 28 °C within 2
hours, during which time the E isomer crystallizes.
[0044] The reaction mixture is seeded with a mixture of the E and Z isomers of N,N-
diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (comprises about 30 % by
weight of the Z- isomer) and mixed at about 28 °C for two hours. Thereafter the mixture
is cooled to 0 °C during which time the Z isomer crystallizes.

[0045] The mixture is filtered and washed with 120 ml of cold water and the filtering
cake is dried. The yield is 77.58 g (93.1 % of the theoretical yield). HPLC purity of the
product is over 99 %.
Example 4 Mixture of the E and Z isomers of N.N-diethvl-2-cvano-3-(3.4-dihvdroxv-5-
nitrophenvl)acrylamide
[0046] A vessel is charged with 100 ml of isoamylalcohol (3-methyl-butanol), 50 g of
3,4-dihyroxy-5-nitrobenzaldehyde, 2 g of methylamine hydrochloride, 50 g of N,N-
diethylcyanoacetamide and 3 ml of piperidine. The temperature is raised using water
separation under vacuum to about 89 °C and the reaction mixture is boiled at this
temperature using water separation for 3 hours. The reaction is followed using HPLC.
[0047] After completing the reaction 220 ml of hot water is added to the reaction
mixture and 1 ml of strong sulphuric acid is added.
[0048] The reaction mixture is cooled to a temperature of 75 °C and seeded with
crude N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (comprises 70 %
by weight of the E- isomer). After seeding the mixture is cooled to about 28 °C within 2
hours, during which time the E isomer crystallizes.
[0049] The reaction mixture is seeded with a mixture of the E and Z isomers of N,N-
diemyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide (comprises about 30 % by
weight of the Z- isomer) and mixed at about 28 °C for two hours. Thereafter the mixture
is cooled to 0 °C during which time the Z isomer crystallizes.
[0050] The mixture is filtered and washed with 120 ml of cold water and the filtering
cake is dried. The yield is 79.0 g (94.8 % of the theoretical yield). HPLC purity of the
product is over 99 %.

WE CLAIM:
1. A process for manufacturing E-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-
nitrophenyl)acrylamide, comprising:
a) reacting 3,4-dihydroxy-5-nitrobenzaldehyde with N,N-diethyl-2-cyanoacetamide in the
presence of a catalyst such as herein described in a C4 to C8 alcohol at less than
atmospheric pressure and at a temperature of at least 70 °C;
b) cooling the mixture from step a) to a temperature of 30 °C or below;
c) seeding the cooled mixture from step b) with N,N-diethyl-2-cyano-3-(3,4- dihydroxy-
5-nitrophenyl)acrylamide comprising at least 10 % of the Z-isomer by weight in the
seeding crystals;
d) cooling the mixture from step c) to a temperature of 5 °C or below;
e) isolating the crystallized product from the mixture; and
f) converting the obtained mixture of the E- and Z-isomers of N,N-diethyl-2-cyano- 3-
(3,4-dihydroxy-5-nitrophenyl)acrylamide to the E-isomer of N,N-diethyl-2- cyano-3-
(3,4-dihydroxy-5-nitrophenyl)acrylamide.

2. The process as claimed in claim 1, wherein the C4 to C8 alcohol is n-butanol.
3. The process as claimed in claim 1 or 2, wherein the less than atmospheric pressure is a
pressure from 80 kPa to 10kPa.
4. The process as claimed in any of claims 1 to 3, wherein the reaction temperature is
from 70 to 105 °C.
5. The process as claimed in any of claims 1 to 4, wherein the catalyst comprises
methylamine hydrochloride and piperidine.

6. The process as claimed in any of claims 1 to 5, which comprises separating water from
the reaction mixture during the reaction.
7. The process as claimed in any of claims 1 to 6, wherein the reaction is carried out
within a time period of from 45 minutes to 6 hours.
8. The process as claimed in any of claims 1 to 7, which optionally comprises step a.i)
wherein the resulting mixture from step a) is cooled to a temperature of from 70 to 75 °C.
9. The process as claimed in any of claims 1 to 8, which optionally comprises step a.ii)
wherein the mixture from step a) or a.i) is seeded with seeding crystals comprising from
65 to 100 % by weight of the E- isomer.

10. The process as claimed in any of claims 1 to 9, wherein the mixture from step a) or
step a.i) or step a.ii) is cooled in step b) to a temperature of from 25 to 30 °C.
11. The process as claimed in any of claims 1 to 10, wherein the mixture is cooled in step
d) to a temperature of-5 to 5 °C.
12. The process as claimed in any of claims 1 to 11, wherein the mixture is seeded in step
c) with seeding crystals comprising from 20 to 100 % by weight of the Z-isomer.
13. The process as claimed in any of claims 1 to 12, wherein the mixture is converted in
step f) to a crystallographically essentially pure polymorph A of the E-isomer.
14. A process for manufacturing E-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-
nitrophenyl)acrylamide, comprising:

a) reacting 3,4-dihydroxy-5-nitrobenzaldehyde with N,N-diethyl-2-cyanoacetamide in the
presence of at least one organic amine and/or its salt in n-butanol at a temperature of from
80 to 85 °C;
b) cooling the resulting mixture from step a) to a temperature of from 25 to 30 °C;

c) seeding the cooled mixture from step b) with N,N-diethyl-2-cyano-3-(3,4- dihydroxy-
5-nitrophenyl)acrylamide comprising from 10 % to 100 % of the Z-isomer by weight in
the seeding crystals;
d) cooling the mixture from step c) to a temperature of from -5 to 5 °C;
e) isolating the crystallized product from the mixture; and
f) converting the obtained mixture of E- and Z-isomers of N,N-diethyl-2-cyano-3- (3,4-
dihydroxy-5-nitrophenyl)acrylamide to the E-isomer of N,N-diethyl-2-cyano-3- (3 ,4-
dihydroxy-5 -m trophenyl)acrylamide.



(54) Tide: PROCESS FOR MANUFACTURING ENTACAPONE


(57) Abstract: A new process for manufacturing entacapone comprising reacting 3,4-dihydroxy-5-nilrobenzaldehyde with N,N-di-
ethyl-2-cyanoacetamide in the presence of a catalyst in a C 4 to 8 alcohol at reduced pressure and at a temperature of at least 70
°C, cooling the mixture to a temperature of 30 °C or below, seeding the mixture with N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-ni-
trophenyl)acrylamide comprising at least 10 % of the Z-isomer by weight in the seeding crystals, cooling the mixture to a temperature
of 5 °C or below, isolating the crystallized product and converting the obtained mixture of the E and Z-isomers of N,N-di-
ethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide to the E-isomer (entacapone).

Documents:

02798-kolnp-2008-abstract.pdf

02798-kolnp-2008-claims.pdf

02798-kolnp-2008-correspondence others.pdf

02798-kolnp-2008-description (complete).pdf

02798-kolnp-2008-form 1.pdf

02798-kolnp-2008-form 3.pdf

02798-kolnp-2008-form 5.pdf

02798-kolnp-2008-gpa.pdf

02798-kolnp-2008-international publication.pdf

02798-kolnp-2008-international search report.pdf

02798-kolnp-2008-pct request form.pdf

2798-KOLNP-2008-(22-10-2013)-ANNEXURE TO FORM 3.pdf

2798-KOLNP-2008-(22-10-2013)-CLAIMS.pdf

2798-KOLNP-2008-(22-10-2013)-CORRESPONDENCE.pdf

2798-KOLNP-2008-(22-10-2013)-FORM-2.pdf

2798-KOLNP-2008-(22-10-2013)-FORM-3.pdf

2798-KOLNP-2008-(22-10-2013)-OTHERS.pdf

2798-KOLNP-2008-(22-10-2013)-PA.pdf

2798-KOLNP-2008-(22-10-2013)-PETITION UNDER RULE 137-1.pdf

2798-KOLNP-2008-(22-10-2013)-PETITION UNDER RULE 137.pdf

2798-KOLNP-2008-ASSIGNMENT-1.1.pdf

2798-KOLNP-2008-ASSIGNMENT.pdf

2798-KOLNP-2008-CANCELLED PAGES.pdf

2798-KOLNP-2008-CORRESPONDENCE-1.1.pdf

2798-KOLNP-2008-CORRESPONDENCE.pdf

2798-KOLNP-2008-EXAMINATION REPORT.pdf

2798-KOLNP-2008-FORM 18.pdf

2798-KOLNP-2008-FORM 3-1.1.pdf

2798-KOLNP-2008-GPA.pdf

2798-KOLNP-2008-GRANTED-ABSTRACT.pdf

2798-KOLNP-2008-GRANTED-CLAIMS.pdf

2798-KOLNP-2008-GRANTED-DESCRIPTION (COMPLETE).pdf

2798-KOLNP-2008-GRANTED-FORM 1.pdf

2798-KOLNP-2008-GRANTED-FORM 2.pdf

2798-KOLNP-2008-GRANTED-FORM 3.pdf

2798-KOLNP-2008-GRANTED-FORM 5.pdf

2798-KOLNP-2008-GRANTED-SPECIFICATION-COMPLETE.pdf

2798-KOLNP-2008-INTERNATIONAL PUBLICATION.pdf

2798-KOLNP-2008-INTERNATIONAL SEARCH REPORT & OTHERS.pdf

2798-KOLNP-2008-PETITION UNDER RULE 137.pdf

2798-KOLNP-2008-REPLY TO EXAMINATION REPORT.pdf


Patent Number 259792
Indian Patent Application Number 2798/KOLNP/2008
PG Journal Number 13/2014
Publication Date 28-Mar-2014
Grant Date 27-Mar-2014
Date of Filing 10-Jul-2008
Name of Patentee ORION CORPORATION
Applicant Address ORIONINTIE 1, FIN 02200 ESPOO
Inventors:
# Inventor's Name Inventor's Address
1 HYTÖNEN, MARTTI HEISIPUUNKUJA 2 A 1, FI-02770 HELSINKI
2 HILDEN, LEIF MIKAEL LYBECKINTIE. 10, FI-02700 KAUNIAINEN
PCT International Classification Number C07C 255/41
PCT International Application Number PCT/FI2007/000029
PCT International Filing date 2007-02-06
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 60/765196 2006-02-06 U.S.A.